Overactive Bladder - Results from #80

Treatment Satisfaction with Flexible-dose Fesoterodine in Patients with Overactive Bladder who were Dissatisfied with Previous Anticholinergic Therapy: A Multicenter Single-Arm Clinical Study. May 26, 2019

New technologies in the management of overactive bladder: current research and future prospects. May 19, 2019

Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB). May 19, 2019

Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis. May 12, 2019

Are We missing out the role of oxytocin in overactive bladder syndrome? May 12, 2019

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. May 5, 2019

How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinA. May 5, 2019

Pathophysiology of refractory overactive bladder. April 28, 2019

Comparison of body composition and overactive bladder symptoms in overweight female university students. April 28, 2019

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry. April 14, 2019

Antimuscarinic drug therapy for overactive bladder syndrome in the elderly - are the concerns justified? April 14, 2019

A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. April 7, 2019

A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). April 7, 2019

Velicept Therapeutics Announces Positive Top-Line Phase 2b Results for Solabegron in the Treatment of Overactive Bladder (OAB) March 28, 2019

Association between the Urinary Bladder Volume and the Incidence of "De Novo" Overactive Bladder in Patients with Stress Urinary Incontinence Subjected to Sling Surgeries or Burch Procedure. March 24, 2019

Randomized, open-label, tolterodine-controlled, comparative study of the novel antimuscarinic agent imidafenacin in patients with overactive bladder. March 24, 2019

Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder March 20, 2019

Using a checklist to increase the effectiveness of behavioral therapy for overactive bladder: A prospective randomized controlled trial. March 17, 2019

Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder. March 17, 2019

Even Younger Nightshift Workers Showing Signs of Frequent Urination, Worsening Quality of Life March 15, 2019

Page 5 of 84